|
JAMA Network Open |
Administration of AntiSARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization |
1 |
Yes |
9/2/2025 |
|
JAMA Dermatology |
Administrative Burden and Costs of Prior Authorizations in a Dermatology Department |
1 |
Yes |
5/20/2025 |
|
JAMA Pediatrics |
Adolescents' Substance Use and Physical Activity Before and During the COVID-19 Pandemic |
1 |
Yes |
5/10/2024 |
|
JAMA Cardiology |
Adult With Unrepaired Single-Ventricle Defect |
1 |
Yes |
9/6/2024 |
|
American Medical Association |
Advanced Rooming and Discharge - Optimize Team-Based Visit Workflows |
0.5 |
Yes |
4/24/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety During COVID-19 |
0.5 |
Yes |
5/5/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety During COVID-19 |
0.5 |
Yes |
5/5/2025 |
|
American Medical Association |
Advancing Equity Through Quality and Safety Peer Network |
0.75 |
Yes |
12/8/2024 |
|
American Medical Association |
Advancing Equity Through Quality and Safety: Five Focus Areas |
0.25 |
Yes |
11/17/2024 |
|
AMA Journal of Ethics |
Advancing Health Equity by Avoiding Judgmentalism and Contextualizing Care |
1 |
Yes |
1/23/2027 |
|
JAMA Internal Medicine |
Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination |
1 |
Yes |
11/5/2024 |
|
JAMA |
Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples |
1 |
Yes |
8/4/2024 |
|
JAMA Network Open |
Age-Varying Susceptibility to the Delta Variant (B.1.617.2) of SARS-CoV-2 |
1 |
Yes |
3/18/2025 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast CancerA Review |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer |
1 |
Yes |
4/21/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Airway Complications Resulting From Pediatric Esophageal Button Battery Impaction |
1 |
Yes |
5/26/2025 |
|
JAMA |
Alcohol-Related Deaths During the COVID-19 Pandemic |
1 |
Yes |
5/9/2025 |
|
American Medical Association |
Aligning Policies to Create an Ethical Practice Environment: Leadership for Ethical Practice |
0.25 |
Yes |
11/30/2024 |
|
JAMA Cardiology |
Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program |
1 |
Yes |
10/25/2024 |
|
JAMA Network Open |
All-Cause Maternal Mortality in the US Before vs During the COVID-19 Pandemic |
1 |
Yes |
8/1/2025 |